Lupin shares down 0.08% as Sensex rises

Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 1267.5 and a 52-week low of Rs 747.65 on NSE. Around 27436 shares changed hands on the counter till 11:52AM (IST).

The stock opened at Rs 778.0 and has touched an intraday high and low of Rs 781.35 and Rs 768.3 during the session so far. The counter quoted a price-to-earnings (PE) ratio of -63.53, earnings per share (EPS) of Rs -12.1 and price to book value (PB) of 3.36, while the return on equity (ROE) stood at Rs 8.93.

Promoter/ FII Holding
The promoters held 46.81 per cent stake in the company as of February 18, while FII and MF ownerships stood at 15.28 per cent and 13.26 per cent, respectively.

Key Financials

With a market capitalisation of Rs 34923.2 crore, the company operates in the Pharma – Indian industry. For the quarter ended 31-Dec-2021, the company reported consolidated sales of Rs 4194.99 crore, up 0.74 per cent from the previous quarter?s Rs 4164.14 crore and up 3.87 per cent from the same quarter a year ago. The company reported net profit of Rs 545.52 crore for the latest quarter, up 24.48 per cent from the corresponding quarter last year.

Technical Indicators
The relative strength index (RSI) of the stock stands at 29.65. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.